Purpose: To evaluate for the presence, severity, and type of exudation at each study visit for a subgroup of patients with neovascular age-related macular degeneration from the Archway and Portal trials.
Design: Retrospective analysis of prospectively obtained data.
Methods: Spectral-domain optical coherence tomography scans from each study visit of 44 patients from the Port Delivery System (PDS) arm and 32 patients from the monthly injection arm of Archway were evaluated, and composites of horizontal scans through the fovea were created. Each composite was graded for the presence, type, and severity of exudation and impact on best-corrected visual acuity.
Results: After PDS implantation, 20 of 44 eyes (45%) never showed any exudation in the fovea, 2 (5%) never showed exudation in the fovea but had several missed visits, whereas 15 (34%), 3 (7%), and 4 (9%) showed mild, moderate, or severe exudation at 1 or more study visits, respectively. When exudation was present, it was most commonly subretinal fluid (50%). Of 32 patients randomized to monthly injections, 15 (47%) had no exudation in the fovea during monthly injections or after PDS implantation. Fluctuation of exudation in the fovea over time was seen in some patients after PDS implantation or during monthly injections with little or no identifiable impact on best-corrected visual acuity. In the 7 eyes with moderate or severe exudation in the fovea after PDS implantation, final vision was good in 5 (20/25 in 3, 20/40 in 1, and 20/50 in 1) and 2 had reduced vision from submacular hemorrhage.
Conclusions: The PDS provides excellent control of exudation in the fovea in patients with neovascular age-related macular degeneration, and when exudation occurs, it often resolves without a negative impact on vision.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajo.2023.07.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acute Submacular Hemorrhage Resulting from Neovascular Age-Related Macular Degeneration in a Monocular Patient.
J Vitreoretin Dis
December 2024
Duke Eye Center, Duke University School of Medicine, Durham, NC, USA.
To present the management and outcomes of a case of acute submacular hemorrhage due to neovascular age-related macular degeneration (nAMD). A single case was retrospectively evaluated. A 79-year-old man with a history of submacular hemorrhage from nAMD and persistent disease activity in the left eye presented with acute submacular hemorrhage in his better-seeing right eye, which was previously closely monitored for an extrafoveal serous pigment epithelial detachment without exudation.
View Article and Find Full Text PDFSurgical outcomes of tractional maculopathy associated with familial exudative vitreoretinopathy in children.
Retina
November 2024
Beijing Tongren Hospital, Capital Medical University, Beijing Tongren Eye Center, Key Laboratory of Beijing Ophthalmology and Visual Science, Beijing, China.
Purpose: To evaluate the surgical outcomes of pediatric familial exudative vitreoretinopathy (FEVR) complicated by tractional maculopathy.
Methods: Retrospective case series. Chart review of 14 children (15 eyes) diagnosed with tractional maculopathy-complicated FEVR who received vitrectomy.
Intraretinal hyperreflective line: potential biomarker in various retinal disorders.
Med Hypothesis Discov Innov Ophthalmol
October 2024
Department of Ophthalmology, Dokuz Eylul University, Izmir, Turkey.
Article Synopsis
- The study investigates the intraretinal hyperreflective line (IHL), a new finding seen through optical coherence tomography (OCT) that suggests damage in the retina's layers due to various conditions.
- Through a retrospective analysis of records from 2019 to 2023, researchers identified IHLs in 40 eyes of 38 participants, noting its connection to various retinal diseases and prior surgeries.
- Key findings included the presence of IHL in 35% of eyes with prior vitreoretinal surgery, as well as associations with conditions like full-thickness macular holes, diabetic macular edema, and idiopathic macular telangiectasia.
Emerging treatments for geographic atrophy and the impact on clinical management of age-related macular degeneration.
Clin Exp Optom
November 2024
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
Age-related macular degeneration (AMD) is a leading cause of vision impairment in people over 50 years of age and has a great impact on quality of life as it affects central vision. Although there have been treatments available for the neovascular form of late AMD for decades, until now there have not been treatments available for the atrophic form of late AMD - geographic atrophy (GA). Recently, treatments acting on the complement pathway have been approved by the United States Food and Drug Administration, with other jurisdictions such as Australia considering their approval.
View Article and Find Full Text PDFTRANSRETINAL PUNCTURE WITH A 41G CANNULA FOR POSTERIOR RESIDUAL SUBRETINAL FLUID IN FOVEA-OFF RETINAL DETACHMENTS TREATED BY VITRECTOMY VS FLUID TOLERANCE VS OTHER CONVENTIONAL DRAINAGE TECHNIQUES: A Comparative Study.
Retina
February 2025
Department of Ophthalmology, Aix-Marseille University, Hôpital Nord, Marseille, France.
Purpose: To compare functional and anatomical outcomes between posterior drainage of residual fluid using a 41G cannula, fluid tolerance (residual subretinal fluid), and conventional complete drainage methods, including removal through peripheral retinal breaks, perfluorocarbon liquid, and posterior retinotomy.
Methods: In this retrospective, multicenter study, we evaluated cases for visual acuity at 3 months of follow-up. Secondary outcomes included surgical success, postoperative metamorphopsia, shifts, full-thickness folds, optical coherence tomography parameters, and safety.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!